BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8197603)

  • 1. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
    Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.
    Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L
    Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
    Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone.
    Alegre ML; Vandenabeele P; Depierreux M; Florquin S; Deschodt-Lanckman M; Flamand V; Moser M; Leo O; Urbain J; Fiers W
    J Immunol; 1991 Feb; 146(4):1184-91. PubMed ID: 1825107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
    Ferran C; Dautry F; Mérite S; Sheehan K; Schreiber R; Grau G; Bach JF; Chatenoud L
    J Clin Invest; 1994 May; 93(5):2189-96. PubMed ID: 8182150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
    Sawchuk SS; Gates R; Hirsch R
    Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels.
    Matthys P; Dillen C; Proost P; Heremans H; Van Damme J; Billiau A
    Eur J Immunol; 1993 Sep; 23(9):2209-16. PubMed ID: 8370401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
    Bemelmans MH; Abramowicz D; Gouma DJ; Goldman M; Buurman WA
    J Immunol; 1994 Jul; 153(2):499-506. PubMed ID: 8021491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation.
    Ferran C; Sheehan K; Dy M; Schreiber R; Merite S; Landais P; Noel LH; Grau G; Bluestone J; Bach JF
    Eur J Immunol; 1990 Mar; 20(3):509-15. PubMed ID: 2138557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice.
    Florquin S; Amraoui Z; Abramowicz D; Goldman M
    J Immunol; 1994 Sep; 153(6):2618-23. PubMed ID: 7915740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.
    Alegre M; Vandenabeele P; Flamand V; Moser M; Leo O; Abramowicz D; Urbain J; Fiers W; Goldman M
    Eur J Immunol; 1990 Mar; 20(3):707-10. PubMed ID: 2138564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy.
    Zhou P; Streutker C; Borojevic R; Wang Y; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G599-604. PubMed ID: 15331352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fish oil decreases secretion of T helper (Th) 1-type cytokines by a direct effect on murine splenic T cells but enhances secretion of a Th2-type cytokine by an effect on accessory cells.
    Petursdottir DH; Hardardottir I
    Br J Nutr; 2009 Apr; 101(7):1040-6. PubMed ID: 18680632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
    Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
    Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.
    Vossen AC; Tibbe GJ; Kroos MJ; van de Winkel JG; Benner R; Savelkoul HF
    Eur J Immunol; 1995 Jun; 25(6):1492-6. PubMed ID: 7614975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.